References
- Abola, M. V., and V. Prasad. 2016. Industry funding of cancer patient advocacy organizations. Mayo Clinic Proceedings 91(11):1668–70. doi: 10.1016/j.mayocp.2016.08.015.
- Ball, D. E., K. Tisocki, and A. Herxheimer. 2006. Advertising and disclosure of funding on patient organisation websites: A cross-sectional survey. BMC Public Health 6(1):201. doi: 10.1186/1471-2458-6-201.
- Claypool, R. 2016. “Patients’ Groups and Big Pharma.” Public Citizen. http://www.citizen.org/documents/patients-groups-and-big-pharma-money-report.pdf.
- DeJong, C., T. Aguilar, C.-W. Tseng, G. A. Lin, W. J. Boscardin, and R. A. Dudley. 2016. Pharmaceutical industry–sponsored meals and physician prescribing patterns for medicare beneficiaries. JAMA Internal Medicine 176(8):1114–22. doi: 10.1001/jamainternmed.2016.2765.
- Elgin, B. 2019. “Pharma’s Secret to Lobbying for Higher Drug Prices?” Bloomberg, April 25, 2019. https://www.bloomberg.com/news/articles/2019-04-25/pharma-s-charity-allies-help-its-fight-to-keep-drug-prices-high.
- Emanuel, E. J., and D. Steiner. 1995. Institutional conflict of interest. New England Journal of Medicine 332(4):262–7. doi: 10.1056/NEJM199501263320412.
- Graham, S. S., D. J. Card, S. Ahn, S.-Y. Kim, M. M. Kessler, and M. K. Olson. 2016. Conflicts of interest among patient and consumer representatives to U.S. Food and Drug Administration Drug Advisory Committees. Annals of Internal Medicine 165(8):606. doi: 10.7326/L16-0031.
- Hilzenrath, David S. 2016. “In FDA Meetings, ‘Voice’ of the Patient Often Funded by Drug Companies.” Project on Government Oversight. http://www.pogo.org/our-work/reports/2016/in-fda-meetings-voice-of-the-patient-often-funded-by-drug-companies.html.
- Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice. 2009. “Conflict of Interest in Medical Research, Education, and Practice.”. Washington (DC): National Academies Press (US).
- “Letter to Secretary Designate Thomas A. Daschle.” 2008. December 2008. http://s.wsj.net/public/resources/documents/FDA_Transition_Statement_FINAL.pdf.
- Kopp, E., S. Lupkin, and E. Lucas. 2018. “Patient Advocacy Groups Take in Millions from Drugmakers. Is There a Payback?” Kaiser Health News (blog). April 6, 2018. https://khn.org/news/patient-advocacy-groups-take-in-millions-from-drugmakers-is-there-a-payback/.
- McCoy, Matthew S. 2018. Industry support of patient advocacy organizations: The case for an extension of the Sunshine Act Provisions of the Affordable Care Act. American Journal of Public Health 108(8):1026–30. doi: 10.2105/AJPH.2018.304467.
- McCoy, M. S., M. Carniol, K. Chockley, J. W. Urwin, E. J. Emanuel, and H. Schmidt. 2017. Conflicts of interest for patient-advocacy organizations. New England Journal of Medicine 376(9):880–5. doi: 10.1056/NEJMsr1610625.
- Meslin, EM., JB. Rager, PH. Schwartz, KA. Quaid, MM. Gaffney, J. Duke, and WH. Tierney. 2015. Benchmarks for ethically credible partnerships between industry and academic health centers: beyond disclosure of financial conflicts of interest. Clinical and Translational Medicine 4 (1):36. doi: 10.1186/s40169-015-0077-y.
- Rose, S. L. 2013. Patient advocacy organizations: Institutional conflicts of interest, trust, and trustworthiness. The Journal of Law, Medicine & Ethics 41(3):680–7. doi: 10.1111/jlme.12078.
- Rose, S. L., J. Highland, M. T. Karafa, and S. Joffe. 2017. Patient advocacy organizations, industry funding, and conflicts of interest. JAMA Internal Medicine 177(3):344–50. doi: 10.1001/jamainternmed.2016.8443.
- Rothman, S. M., V. H. Raveis, A. Friedman, and D. J. Rothman. 2011. Health advocacy organizations and the pharmaceutical industry: An analysis of disclosure practices. American Journal of Public Health 101(4):602–9. doi: 10.2105/AJPH.2010.300027.
- Sen Grassley, C. 2009. Physician Payments Sunshine Act of 2009.
- Thomas, K. 2016. “Furor Over Drug Prices Puts Patient Advocacy Groups in Bind.” The New York Times, September 27, 2016. http://www.nytimes.com/2016/09/28/business/furor-over-drug-prices-puts-patient-advocacy-groups-in-bind.html.
- Thompson, D. F. 2009. The challenge of conflict of interest in medicine. Zeitschrift Fur Evidenz, Fortbildung Und Qualitat im Gesundheitswesen 103(3):136–40.
- Weinberg, M. 2010. “Letter to Members of 111th Congress,” January 20, 2010. http://www.nationalhealthcouncil.org/sites/default/files/NHC_Files/Pdf_Files/NHCLetter01202010_01-2 0-10.pdf.